Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

1.

Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.

Parashos SA, Luo S, Biglan KM, Bodis-Wollner I, He B, Liang GS, Ross GW, Tilley BC, Shulman LM; NET-PD Investigators.

JAMA Neurol. 2014 Jun;71(6):710-6. doi: 10.1001/jamaneurol.2014.391.

PMID:
24711047
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A randomized study of rotigotine dose response on 'off' time in advanced Parkinson's disease.

Nicholas AP, Borgohain R, Chaná P, Surmann E, Thompson EL, Bauer L, Whitesides J, Elmer LW; SP921 Study Investigators.

J Parkinsons Dis. 2014;4(3):361-73. doi: 10.3233/JPD-130320.

PMID:
24643203
[PubMed - in process]
3.

Phonemic verbal fluency decline after subthalamic nucleus deep brain stimulation does not depend on number of microelectrode recordings or lead tip placement.

Smith KM, O'Connor M, Papavassiliou E, Tarsy D, Shih LC.

Parkinsonism Relat Disord. 2014 Apr;20(4):400-4. doi: 10.1016/j.parkreldis.2014.01.008. Epub 2014 Jan 20.

PMID:
24495709
[PubMed - in process]
4.

Timed up and go, cognitive, and quality-of-life correlates in Parkinson's disease.

Stegemöller EL, Nocera J, Malaty I, Shelley M, Okun MS, Hass CJ; NPF Quality Improvement Initiative Investigators.

Arch Phys Med Rehabil. 2014 Apr;95(4):649-55. doi: 10.1016/j.apmr.2013.10.031. Epub 2013 Nov 27.

PMID:
24291596
[PubMed - indexed for MEDLINE]
5.

Mobility, mood and site of care impact health related quality of life in Parkinson's disease.

Nutt JG, Siderowf AD, Guttman M, Schmidt PN, Zamudio JI, Wu SS, Okun MS, Simuni T, Parashos SA, Dahodwala NA, Davis TL, Giladi N, Gurevich T, Hauser RA, Jankovic J, Lyons KE, Marsh L, Miyasaki JM, Morgan JC, Santiago AJ, Tarsy D, Mari Z, Malaty IA, Nelson EC; National Parkinson Foundation Quality Improvement Initiative Investigators.

Parkinsonism Relat Disord. 2014 Mar;20(3):274-9. doi: 10.1016/j.parkreldis.2013.10.004. Epub 2013 Oct 16.

PMID:
24182524
[PubMed - in process]
6.

The current state and needs of north american movement disorders fellowship programs.

Shih LC, Tarsy D, Okun MS.

Parkinsons Dis. 2013;2013:701426. doi: 10.1155/2013/701426. Epub 2013 Jul 25.

PMID:
23984186
[PubMed]
Free PMC Article
7.

Novel use of dual immunomodulation for treating stiff-person syndrome, cerebellar variant.

Sengupta S, Tarsy D, Joyce R, Jeyapalan S.

Mov Disord. 2013 Nov;28(13):1905-6. doi: 10.1002/mds.25574. Epub 2013 Jul 9. No abstract available.

PMID:
23839936
[PubMed - indexed for MEDLINE]
8.

Sternutatory reflex induced by periocular needle insertion in patients receiving chronic botulinum toxin injections.

Kulkarni OC, Cox CA, Hedges TR 3rd, Tarsy D.

Parkinsonism Relat Disord. 2013 Aug;19(8):770-1. doi: 10.1016/j.parkreldis.2013.04.014. Epub 2013 May 13. No abstract available.

PMID:
23680422
[PubMed - indexed for MEDLINE]
9.

The "floating door sign" in Parkinson's disease.

Kulkarni O, Lafaver K, Tarsy D.

Parkinsonism Relat Disord. 2013 Sep;19(9):825-6. doi: 10.1016/j.parkreldis.2013.04.013. Epub 2013 May 7.

PMID:
23660546
[PubMed - indexed for MEDLINE]
10.

Initial treatment of Parkinson's disease: an update.

Kaplan S, Tarsy D.

Curr Treat Options Neurol. 2013 Aug;15(4):377-84. doi: 10.1007/s11940-013-0236-7.

PMID:
23645294
[PubMed]
11.

Loss of benefit in VIM thalamic deep brain stimulation (DBS) for essential tremor (ET): how prevalent is it?

Shih LC, LaFaver K, Lim C, Papavassiliou E, Tarsy D.

Parkinsonism Relat Disord. 2013 Jul;19(7):676-9. doi: 10.1016/j.parkreldis.2013.03.006. Epub 2013 Apr 11.

PMID:
23582712
[PubMed - indexed for MEDLINE]
12.

Thalamic and subthalamic deep brain stimulation for parkinsonian tremor: are two circuits involved?

Kulkarni O, Lafaver K, Papavassiliou E, Tarsy D, Shih LC.

Mov Disord. 2013 Apr;28(4):554-5. doi: 10.1002/mds.25299. Epub 2013 Feb 6. No abstract available.

PMID:
23389961
[PubMed - indexed for MEDLINE]
13.

Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER.

LeWitt PA, Boroojerdi B, Surmann E, Poewe W; SP716 Study Group; SP715 Study Group.

J Neural Transm. 2013 Jul;120(7):1069-81. doi: 10.1007/s00702-012-0925-5. Epub 2012 Dec 4.

PMID:
23208198
[PubMed - indexed for MEDLINE]
Free PMC Article
14.
15.

Psychogenic facial movement disorders: clinical features and associated conditions.

Fasano A, Valadas A, Bhatia KP, Prashanth LK, Lang AE, Munhoz RP, Morgante F, Tarsy D, Duker AP, Girlanda P, Bentivoglio AR, Espay AJ.

Mov Disord. 2012 Oct;27(12):1544-51. doi: 10.1002/mds.25190. Epub 2012 Oct 2.

PMID:
23033125
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Reliability of a new scale for essential tremor.

Elble R, Comella C, Fahn S, Hallett M, Jankovic J, Juncos JL, Lewitt P, Lyons K, Ondo W, Pahwa R, Sethi K, Stover N, Tarsy D, Testa C, Tintner R, Watts R, Zesiewicz T.

Mov Disord. 2012 Oct;27(12):1567-9. doi: 10.1002/mds.25162. Epub 2012 Oct 2.

PMID:
23032792
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Efficacy, tolerability, and immunogenicity of onabotulinumtoxina in a randomized, double-blind, placebo-controlled trial for cervical dystonia.

Charles D, Brashear A, Hauser RA, Li HI, Boo LM, Brin MF; CD 140 Study Group.

Clin Neuropharmacol. 2012 Sep-Oct;35(5):208-14.

PMID:
22948497
[PubMed - indexed for MEDLINE]
18.

Treatment of Parkinson disease: a 64-year-old man with motor complications of advanced Parkinson disease.

Tarsy D.

JAMA. 2012 Jun 6;307(21):2305-14. doi: 10.1001/jama.2012.4829.

PMID:
22706836
[PubMed - indexed for MEDLINE]
19.

Singing in groups for Parkinson's disease (SING-PD): a pilot study of group singing therapy for PD-related voice/speech disorders.

Shih LC, Piel J, Warren A, Kraics L, Silver A, Vanderhorst V, Simon DK, Tarsy D.

Parkinsonism Relat Disord. 2012 Jun;18(5):548-52. doi: 10.1016/j.parkreldis.2012.02.009. Epub 2012 Mar 19.

PMID:
22436653
[PubMed - indexed for MEDLINE]
20.

Survey of U.S. neurologists' attitudes towards deep brain stimulation for Parkinson's disease.

Shih LC, Tarsy D.

Neuromodulation. 2011 May-Jun;14(3):208-13; discussion 213. doi: 10.1111/j.1525-1403.2011.00350.x. Epub 2011 Apr 1.

PMID:
21992241
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk